primordiale optimum spf 15 peau normale a mixte lotion
lancome canada - ensulizole; octinoxate - lotion - 2%; 7.5% - ensulizole 2%; octinoxate 7.5% - sunscreen agents
primordiale skin recharge crème/cream
lancome canada - ensulizole; octinoxate - cream - 1.8%; 7.5% - ensulizole 1.8%; octinoxate 7.5% - sunscreen agents
primordiale skin recharge lotion
lancome canada - ensulizole; octinoxate - lotion - 2%; 7.5% - ensulizole 2%; octinoxate 7.5% - sunscreen agents
4% astracaine dental with epinephrine forte 1:100,000 (0.01mg/ml) solution
dentsply canada limited - articaine hydrochloride; epinephrine (epinephrine bitartrate) - solution - 40mg; 0.01mg - articaine hydrochloride 40mg; epinephrine (epinephrine bitartrate) 0.01mg - local anesthetics
4% citanest forte dental with epinephrine 1:200,000 solution
dentsply canada limited - prilocaine hydrochloride; epinephrine - solution - 40mg; 0.005mg - prilocaine hydrochloride 40mg; epinephrine 0.005mg - local anesthetics
leukeran- chlorambucil tablet, film coated
woodward pharma services llc - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.
leukeran- chlorambucil tablet, film coated
aspen global inc. - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - chlorambucil 2 mg - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.
leukeran- chlorambucil tablet, film coated
waylis therapeutics llc - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.
ptelea trifoliata- ptelea trifoliata bark pellet
washington homeopathic products - ptelea - to relieve the symptoms of headache. indications: ptelea headache if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.
ptelea trifoliata- ptelea trifoliata bark liquid
washington homeopathic products - ptelea - to relieve the symptoms of headache. indications: ptelea headache if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.